SCHEMBL8308214

SCHEMBL8308214

CCCCN1CCC(n2nc(-c3cc(Cl)c(N)cc3OCC3CC3)oc2=O)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 11/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43
ACHE P22303 1/20 0.43
KMT2A Q03164 1/20 0.43
HTR3A P46098 3/20 0.39
HTR2C P28335 2/20 0.39
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
ADRA2C P18825 2/20 0.38
HTR1D P28221 2/20 0.38
HTR2B P41595 2/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8364678 0.99 HTR4 (0.43) HTR4CYP2D6CYP2C9MEN1ALDH1A1
SCHEMBL6961633 0.84 HTR4 (0.47) HTR4CYP2D6CYP2C9MEN1ALDH1A1
Bromide SCHEMBL7744560 0.84 HTR4 (0.46) HTR4CYP2D6CYP2C9MEN1ALDH1A1
SCHEMBL8306432 0.77 HTR4 (0.53) HTR4CYP2D6CYP2C9HTR3AHTR2C
SCHEMBL8305104 0.77 HTR4 (0.44) HTR4
SCHEMBL8309549 0.77 ACHE (0.51) HTR4ACHESIGMAR1
Hydrochloric Acid SCHEMBL8364693 0.77 HTR4 (0.52) HTR4CYP2D6CYP2C9HTR3AHTR2C
SCHEMBL8309535 0.76 DRD4 (0.44) HTR4CYP2D6CYP2C9ACHEHTR3A
Hydrochloric Acid SCHEMBL8368070 0.76 HTR4 (0.43) HTR4
SCHEMBL8304880 0.71 HTR4 (0.44) HTR4ACHEHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863897-B1 5-PHENYL-3-(PIPERIDIN-4-YL)-1,3,4-OXADIAZOL-2(3H)-ONE DERIVATIVES FOR USE AS 5-HT4- OR H3-RECEPTOR LIGANDS SYNTHELABO (FR) 1999-06-16 EP disclosed